Id Boufker, H., Lagneaux, L., Najar, M., Piccart, M., Ghanem, G., Body, J., & Journé, F. (2010). The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BioMed Central.

Id Boufker, Hichame, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean-Jacques Body, and Fabrice Journé. The Src Inhibitor Dasatinib Accelerates the Differentiation of Human Bone Marrow-derived Mesenchymal Stromal Cells Into Osteoblasts. BioMed Central, 2010.

Id Boufker, Hichame, et al. The Src Inhibitor Dasatinib Accelerates the Differentiation of Human Bone Marrow-derived Mesenchymal Stromal Cells Into Osteoblasts. BioMed Central, 2010.